全文获取类型
收费全文 | 94948篇 |
免费 | 9557篇 |
国内免费 | 5571篇 |
专业分类
耳鼻咽喉 | 113篇 |
儿科学 | 4025篇 |
妇产科学 | 385篇 |
基础医学 | 7540篇 |
口腔科学 | 505篇 |
临床医学 | 8408篇 |
内科学 | 24232篇 |
皮肤病学 | 622篇 |
神经病学 | 1486篇 |
特种医学 | 3230篇 |
外国民族医学 | 20篇 |
外科学 | 24266篇 |
综合类 | 14965篇 |
现状与发展 | 31篇 |
一般理论 | 2篇 |
预防医学 | 2697篇 |
眼科学 | 1268篇 |
药学 | 6813篇 |
38篇 | |
中国医学 | 4525篇 |
肿瘤学 | 4905篇 |
出版年
2024年 | 87篇 |
2023年 | 1617篇 |
2022年 | 1981篇 |
2021年 | 3440篇 |
2020年 | 3781篇 |
2019年 | 3602篇 |
2018年 | 3595篇 |
2017年 | 3691篇 |
2016年 | 4046篇 |
2015年 | 3713篇 |
2014年 | 6093篇 |
2013年 | 6415篇 |
2012年 | 5151篇 |
2011年 | 6055篇 |
2010年 | 5008篇 |
2009年 | 4971篇 |
2008年 | 5088篇 |
2007年 | 5307篇 |
2006年 | 5232篇 |
2005年 | 4524篇 |
2004年 | 3656篇 |
2003年 | 3150篇 |
2002年 | 2661篇 |
2001年 | 2347篇 |
2000年 | 1973篇 |
1999年 | 1554篇 |
1998年 | 1392篇 |
1997年 | 1200篇 |
1996年 | 1096篇 |
1995年 | 978篇 |
1994年 | 1028篇 |
1993年 | 691篇 |
1992年 | 787篇 |
1991年 | 582篇 |
1990年 | 473篇 |
1989年 | 422篇 |
1988年 | 403篇 |
1987年 | 306篇 |
1986年 | 258篇 |
1985年 | 296篇 |
1984年 | 243篇 |
1983年 | 150篇 |
1982年 | 187篇 |
1981年 | 157篇 |
1980年 | 129篇 |
1979年 | 109篇 |
1978年 | 109篇 |
1977年 | 89篇 |
1976年 | 100篇 |
1975年 | 43篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
91.
《Journal of pediatric surgery》2023,58(9):1715-1726
ObjectiveTo compare the outcomes of patients with multifocal hepatoblastoma (HB) treated at our institution with either orthotopic liver transplant (OLTx) or hepatic resection to determine outcomes and risk factors for recurrence.BackgroundMultifocality in HB has been shown to be a significant prognostic factor for recurrence and worse outcome. The surgical management of this type of disease is complex and primarily involves OLTx to avoid leaving behind microscopic foci of disease in the remnant liver.MethodsWe performed a retrospective chart review on all patients <18 years of age with multifocal HB treated at our institution between 2000 and 2021. Patient demographics, operative procedure, post-operative course, pathological data, laboratory values, short- and long-term outcomes were analyzed.ResultsA total of 41 patients were identified as having complete radiologic and pathologic inclusion criteria. Twenty-three (56.1%) underwent OLTx and 18 (43.9%) underwent partial hepatectomy. Median length of follow-up across all patients was 3.1 years (IQR 1.1–6.6 years). Cohorts were similar in rates of PRETEXT designation status identified on standardized imaging re-review (p = .22). Three-year overall survival (OS) estimate was 76.8% (95% CI: 60.0%–87.3%). There was no difference in rates of recurrence or overall survival in patients who underwent either resection or OLTx (p = .54 and p = .92 respectively). Older patients (>72 months), patients with a positive porta hepatis margin, and patients with associated tumor thrombus experienced worse recurrence rates and survival. Histopathology demonstrating pleomorphic features independently associated with worse rates of recurrence.ConclusionsThrough proper patient selection, multifocal HB was adequately treated with either partial hepatectomy or OLTx with comparable outcome results. HB with pleomorphic features, increased patient age at diagnosis, involved porta hepatis margin on pathology, and the presence of associated tumor thrombus may be associated with worse outcomes regardless of the local control surgery offered.Level of EvidenceIII. 相似文献
92.
93.
94.
95.
《Biomedical and environmental sciences : BES》2022,35(9):804-810
ObjectiveTo detect the Epstein-Barr virus (EBV) viral load of children after hematopoietic stem cell transplantation (HSCT) using chip digital PCR (cdPCR).MethodsThe sensitivity of cdPCR was determined using EBV plasmids and the EBV B95-8 strain. The specificity of EBV cdPCR was evaluated using the EBV B95-8 strain and other herpesviruses (herpes simplex virus 1, herpes simplex virus 2, varicella zoster virus, human cytomegalovirus, human herpesvirus 6, and human herpesvirus 7). From May 2019 to September 2020, 64 serum samples of children following HSCT were collected. EBV infection and the viral load of serum samples were detected by cdPCR. The epidemiological characteristics of EBV infections were analyzed in HSCT patients.ResultsThe limit of detection of EBV cdPCR was 110 copies/mL, and the limit of detection of EBV quantitative PCR was 327 copies/mL for the pUC57-BALF5 plasmid. The result of EBV cdPCR was up to 121 copies/mL in the EBV B95-8 strain, and both were more sensitive than that of quantitative PCR. Using cdPCR, the incidence of EBV infection was 18.75% in 64 children after HSCT. The minimum EBV viral load was 140 copies/mL, and the maximum viral load was 3,209 copies/mL using cdPCR. The average hospital stay of children with EBV infection (184 ± 91 days) was longer than that of children without EBV infection (125 ± 79 days), P = 0.026.ConclusionEBV cdPCR had good sensitivity and specificity. The incidence of EBV infection was 18.75% in 64 children after HSCT from May 2019 to September 2020. EBV cdPCR could therefore be a novel method to detect EBV viral load in children after HSCT. 相似文献
96.
《Clinical microbiology and infection》2022,28(6):779-784
BackgroundThe COVID-19 pandemic has influenced the field of solid organ transplantation (SOT) in many ways. COVID-19 has led to programmatic impacts and changes in donor and recipient selection. Several studies have evaluated the course, optimal treatment, and prevention of COVID-19 in SOT recipients.ObjectivesTo review the literature on COVID-19 in SOT recipients.SourcesPubMed, Web of Science, and Google Scholar were searched. The search was restricted to articles published between January 1, 2019 and December 1, 2021.ContentThe COVID-19 pandemic initially led to a decreased volume of solid organ transplants. However, transplant volumes at most centres have rebounded. Donor selection remains an incompletely defined issue. Several reports suggest that donor-derived SARS-CoV-2 infections occur only in lung transplant recipients and that other organs from SARS-CoV-2 PCR-positive donors could potentially be safely used. However, these data are limited to case series. Transplantation for end-stage lung disease after COVID-19 infection is increasingly common and has been performed with acceptable outcomes. In acute COVID-19 in a transplant candidate, transplantation should be delayed when feasible. After adjustment, mortality after COVID-19 appear similar in SOT recipients compared to the general population, with notable increased use of antiviral and anti-inflammatory treatment options. Prevention of COVID-19 is key in SOT recipients. Vaccination of SOT recipients and anyone who is in contact with SOT recipients is one of the cornerstones of prevention. Nonpharmacological interventions such as face coverings, hand hygiene, and physical distancing remain ever important as well.ImplicationsThe COVID-19 pandemic continues to have an important impact on SOT candidates and recipients. Prevention of infection is the most important measure and requires careful attention to approaches to vaccination and messaging of the ongoing need for face coverings, physical distancing, and hand hygiene. 相似文献
97.
Donor lungs cold preservation at 10 °C offers a potential logistic advantage in lung transplantation
《Cirugía espa?ola》2023,101(4):283-286
Donor lung preservation at 10 °C appears to be an innovative and promising method that may improve transplant logistics by extending the cold ischemia time with excellent outcomes. We report the case of two lung transplants from two different donors involving the use of two different preservation methods, highlighting the benefits of using 10 °C lung storage. 相似文献
98.
Won Sohn Yoosoo Chang Yong Kyun Cho Yun Soo Hong Hocheol Shin Seungho Ryu 《Journal of viral hepatitis》2022,29(1):69-77
The predictive role of noninvasive liver fibrosis scores on liver-related mortality in patients with chronic hepatitis B below 40 years of age remains unclarified. We examined the association of liver fibrosis scores with liver-related mortality in young (<40 years) and older adults with hepatitis B virus (HBV) infection. A cohort study was performed in 21,360 HBsAg-positive Korean adults without liver cirrhosis or liver cancer at baseline who were followed up for up to 18 years. The liver fibrosis scores were determined using the fibrosis-4 score (FIB-4) and aspartate transaminase to platelet ratio index (APRI). Patients’ vital status and cause of death were ascertained through the National Death Records. During a median follow-up of 10.2 years, 283 liver-related deaths were identified (liver-related mortality, 127.4/105 person-years). The liver fibrosis scores were significantly associated with increased risks of liver-related mortality; this association did not differ by age group (<40 vs. ≥40 years). The multivariable-adjusted hazard ratios with 95% confidence intervals for liver-related mortality comparing intermediate and high to low FIB-4 scores were 4.23 (1.99–9.00), and 15.16 (5.18–44.38), respectively, among individuals under 40, and 4.46 (3.03–6.56) and 22.47 (15.11–33.41), respectively, among older individuals. These associations were similar in analyses using APRI. In this cohort of HBsAg-positive individuals, the liver fibrosis scores were associated with increased risks of liver-related mortality in young and older adults. The liver fibrosis scores have a role in predicting liver mortality, even in young adults with HBV. 相似文献
99.
[摘要] 目的 探究HBV相关慢加急性肝衰竭(HBV-related acute-on-chronic liver failure, HBV-ACLF)患者血清中微小核糖核酸(microRNA, miR)-122和高迁移率族蛋白1(high-mobility group box-B1, HMGB1)水平及其与病情、预后的关系。方法 回顾性分析2016年1月—2018年1月我院收治的120例HBV-ACLF患者的一般及临床资料。根据临床结局,将患者分为存活组(53例)和死亡组(67例)。比较2组患者的一般资料、实验室检查指标及血清miR-122、HMGB1水平。多因素Logistic回归分析影响患者预后的因素。Pearson检验分析miR-122、HMGB1水平分别与TBIL、PA、终末期肝病评分模型(the model of end-stage liver disease score, MELD)评分的相关性。ROC曲线分析miR-122和HMGB1水平对患者的死亡预测价值,获得最佳临界值。根据临界值将患者分为A组、B组和C组,用Kaplan-Meier法绘制生存曲线,比较3组患者在3年随访期间的生存率。结果 存活组和死亡组患者的年龄、身体质量指数、并发症、病情分期、MELD评分、ALB、球蛋白、TBIL、ALT、AST、LDH、PT、PTA、HBV DNA、miR-122、HMGB1相比,差异均具有统计学意义(P均<0.05)。年龄、并发症、病情分期、MELD评分、TBIL、PT、PTA、miR-122、HMGB1均是影响患者预后的危险因素(P均<0.05)。miR-122、HMGB1水平分别与TBIL、MELD评分呈显著正相关,与PTA呈显著负相关(P均<0.05)。miR-122和HMGB1预测患者死亡的最佳临界值分别为31.42和14.56 μg/L。A组患者预后3年内生存率显著高于B组和C组(P均<0.05)。结论 miR-122和HMGB1水平与HBV-ACLF患者的病情和死亡预后密切相关,可间接反映患者的病情严重程度,在HBV-ACLF的诊断及预后中具有重要价值。 相似文献
100.
《The Knee》2021
BackgroundOur study purpose was to determine if primary osteochondral allograft (OCA) transplant surgeries for large (>4 cm2) single-surface, multisurface, or bipolar articular defects in the knee would be associated with significant gains in knee range of motion (ROM) at ≥1-year follow-up when compared to preoperative ROM.MethodsPatients were prospectively enrolled into a dedicated registry to follow outcomes after OCA with or without meniscal allograft transplantation using Missouri Osteochondral Preservation System (MOPS)-preserved allografts. Patients were included if they had surgery to repair at least one osteochondral defect, and when at least one year of ROM data and Visual Analog Scale pain scores were available. Data on complications and reoperations, patient-reported outcome measures, compliance with rehabilitation, revisions, or failures were recorded.ResultsFor patients who met inclusion criteria after OCA surgery (n = 75), overall ROM increased from 127.8 ± 17 degrees preoperatively, to 130.5 ± 14 post-operatively. Non-compliance was the largest factor contributing to postoperative ROM lag or loss. Knee manipulation/lysis of adhesion rates were comparable to rates in TKA and ACL procedures (2.96–4.54% for ACL/TKA, 4% for OCAs in the present study).ConclusionResults suggest that OCA with or without meniscal allograft transplantation in the knee using high-viability grafts, advanced graft cutting and implantation techniques, and procedure-specific rehabilitation protocols can result in consistently successful outcomes in a high percentage (92%) of selected patients. Most patients (95%) can expect to regain, or improve, to “full” functional range of motion (130°) at 1 year after surgery such that highly functional activities can be performed.Level of Evidence: Cohort study; Level III. 相似文献